Abstract
Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Current Cancer Drug Targets
Title: Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Volume: 7 Issue: 7
Author(s): Zhuo (Georgia) Chen
Affiliation:
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Abstract: Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Export Options
About this article
Cite this article as:
Chen (Georgia) Zhuo, Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418301
DOI https://dx.doi.org/10.2174/156800907782418301 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Low Doses Naltrexone: The Potential Benefit Effects for its Use in Patients with Cancer
Current Drug Research Reviews Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Genetics of Bladder Malignant Tumors in Childhood
Current Genomics CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Radiation Protection of the Child from Diagnostic Imaging
Current Pediatric Reviews Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting
Current Gene Therapy Nanotechnology and Radiopharmaceuticals: Diagnostic and Therapeutic Approaches
Current Drug Delivery MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Current Cancer Drug Targets New Approaches to Postoperative Radiotherapy for Cancer of the Head and Neck
Current Cancer Therapy Reviews Current Prodrug Design for Drug Discovery
Current Pharmaceutical Design Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors
Current Cancer Drug Targets COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy
Current Pharmaceutical Design Towards Multifunctional Synthetic Vectors
Current Gene Therapy Molecular Dynamics of Protein Kinase-Inhibitor Complexes: A Valid Structural Information
Current Pharmaceutical Design The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
Current Pharmaceutical Design Cisplatin and Probiotic Biomass Loaded Pessaries for the Management of Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry